文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性呼吸窘迫综合征流行病学、治疗模式与结局的地理经济差异:LUNG SAFE前瞻性队列研究启示

Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study.
PubMed 文献 · Lancet Respir Med · 2017-06-15
一句话结论LUNG SAFE研究显示,急性呼吸窘迫综合征(ARDS)的严重程度、临床识别、治疗与结局存在显著地理经济差异,人均国民总收入与ARDS生存独立相关。

LUNG SAFE为2014年冬季连续4周、50个国家459个ICU的前瞻性队列研究,纳入2813例第1或2天符合ARDS标准的机械通气患者,按世界银行2016年分类分为欧洲高收入、世界其他地区高收入和中收入三组。中收入国家医院生存率显著低于欧洲高收入和其他地区高收入国家;其他地区高收入国家重症ARDS或PaO2/FiO2<150比例显著更低,俯卧位通气和神经肌肉阻滞使用显著少于欧洲高收入国家,调整后有创机械通气时间和ICU住院时间显著更短。人均国民总收入高与ARDS生存增加相关,人均收入与ARDS结局独立相关。

要点

  • 中收入国家ARDS患者医院生存率显著低于欧洲高收入国家和世界其他地区高收入国家。
  • 世界其他地区高收入国家重症ARDS或PaO2/FiO2<150的比例显著低于欧洲高收入国家和中收入国家。
  • 欧洲高收入国家俯卧位通气和神经肌肉阻滞的使用显著多于世界其他地区高收入国家和中收入国家。
  • 调整后有创机械通气持续时间和ICU住院时间在世界其他地区高收入国家显著短于欧洲高收入国家和中收入国家。
  • 人均国民总收入高与ARDS生存增加相关,人均收入与ARDS结局独立相关。

适用人群与场景

  • 2014年冬季连续4周内入住参与ICU(包括转入)并接受有创或无创通气的患者。
  • 第1天或第2天符合ARDS标准的2813例患者纳入本分析。
  • 按世界银行2016年国家分类分为欧洲高收入国家、世界其他地区高收入国家和中收入国家三组。

诊断标准与关键阈值

  • ARDS诊断依据第1天或第2天符合ARDS标准。
  • 严重ARDS或PaO2/FiO2<150的比例在世界其他地区高收入国家显著低于欧洲高收入国家和中收入国家。

研究设计与关键结果

  • LUNG SAFE为2014年冬季连续4周、50个国家459个ICU的前瞻性队列研究,2813例第1或2天符合ARDS标准的患者纳入分析。
  • 2813例中欧洲高收入国家1521例(54%)、世界其他地区高收入国家746例(27%)、中收入国家546例(19%)。
  • 中收入国家医院生存率显著低于欧洲高收入国家和世界其他地区高收入国家。
  • 世界其他地区高收入国家重症ARDS或PaO2/FiO2<150的比例显著低于欧洲高收入国家和中收入国家。
  • 欧洲高收入国家俯卧位通气和神经肌肉阻滞的使用显著多于世界其他地区高收入国家和中收入国家。
  • 调整后有创机械通气持续时间和ICU住院时间在世界其他地区高收入国家显著短于欧洲高收入国家和中收入国家。
  • 人均国民总收入高与ARDS生存增加相关。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究(LUNG SAFE),注册号NCT02010073。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 研究提示ARDS的严重程度、临床识别、治疗与结局存在地理经济差异,人均收入与ARDS结局独立相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Little information is available about the geo-economic variations in demographics, management, and outcomes of patients with acute respiratory distress syndrome (ARDS). We aimed to characterise the effect of these geo-economic variations in patients enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE).

METHODS: LUNG SAFE was done during 4 consecutive weeks in winter, 2014, in a convenience sample of 459 intensive-care units in 50 countries across six continents. Inclusion criteria were admission to a participating intensive-care unit (including transfers) within the enrolment window and receipt of invasive or non-invasive ventilation. One of the trial's secondary aims was to characterise variations in the demographics, management, and outcome of patients with ARDS. We used the 2016 World Bank countries classification to define three major geo-economic groupings, namely European high-income countries (Europe-High), high-income countries in the rest of the world (rWORLD-High), and middle-income countries (Middle). We compared patient outcomes across these three groupings. LUNG SAFE is registered with ClinicalTrials.gov, number NCT02010073.

FINDINGS: Of the 2813 patients enrolled in LUNG SAFE who fulfilled ARDS criteria on day 1 or 2, 1521 (54%) were recruited from Europe-High, 746 (27%) from rWORLD-High, and 546 (19%) from Middle countries. We noted significant geographical variations in demographics, risk factors for ARDS, and comorbid diseases. The proportion of patients with severe ARDS or with ratios of the partial pressure of arterial oxygen (PaO2) to the fractional concentration of oxygen in inspired air (FiO2) less than 150 was significantly lower in rWORLD-High countries than in the two other regions. Use of prone positioning and neuromuscular blockade was significantly more common in Europe-High countries than in the other two regions. Adjusted duration of invasive mechanical ventilation and length of stay in the intensive-care unit were significantly shorter in patients in rWORLD-High countries than in Europe-High or Middle countries. High gross national income per person was associated with increased survival in ARDS; hospital survival was significantly lower in Middle countries than in Europe-High or rWORLD-High countries.

INTERPRETATION: Important geo-economic differences exist in the severity, clinician recognition, and management of ARDS, and in patients' outcomes. Income per person and outcomes in ARDS are independently associated.

FUNDING: European Society of Intensive Care Medicine, St Michael's Hospital, University of Milan-Bicocca.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Laffey JG, Madotto F, Bellani G, et al. Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study. Lancet Respir Med. 2017. PMID: 28624388. doi:10.1016/S2213-2600(17)30213-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。